Report Highlights
The global market for IV therapy and vein access will grow from nearly $40.7 billion in 2018 to $54.5 billion by 2023 with a compound annual growth rate (CAGR) of 6.0% for the period of 2018-2023.
Report Includes
- 98 data tables and 43 additional tables
- An overview of global markets for the intravenous (IV) therapy and vein access within the industry
- Analyses of global market trends with data from 2017,2018, and projections of compound annual growth rates (CAGRs) through 2023
- Encompassing details of different types of IV solutions and devices used for therapeutic purposes
- Coverage of the associated regulatory aspects such as innovations and technological improvements (patents and approvals), latest trends, preferences and progress in the field of IV therapy
- Detailed information on the main categories for IV therapy, including ambulatory infusion pumps, central venous access devices, diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps
- Examination of the vendor landscape and market shares of leading global players
- Profiles of the companies related to the industry, including B. Braun Melsungen, Fresenius Kabi; Medtronic, Teleflex, Insulet Corp., Tandem Diabetes Care and Nestle Health Science
Report Scope
This report focuses on the global market for IV therapy and vein access devices and provides an updated review that includes applications in various care facility settings.
The scope of this study encompasses different types of IV solutions and devices used for therapeutic purposes. BCC Research studied and analyzed the market for key components including different types of intravenous solutions and sets (general IV solutions and sets, parenteral nutrition IV solutions and sets and premixed drug IV solutions and sets), infusion pumps (large-volume infusion pumps, syringe infusion pumps, ambulatory/disposable infusion pumps, insulin infusion pumps, PCA infusion pumps, enteraI feeding pumps and implantable infusion pumps) and vein access devices (peripheral intravenous catheters and central venous catheters).
Below are the details of product inclusions studied for each market segment under IV solutions and sets:
- General IV solutions and sets include intravenous solutions with a ranging composition of normal saline (0.9% normal saline (0.9% NaCl), hypertonic saline, Lactated Ringer’s, Dextran, dextrose in water and others. This market also covers the IV sets and containers, associated accessories and consumables provided with general IV solution kits marketed to care settings only.
- Parenteral nutrition IV solution and sets covers the market for IV solutions containing vitals nutrients such as carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, vitamins and minerals. This market also covers the market for IV sets and containers, associated accessories and consumables provided with parenteral IV solution kits marketed to care settings only.
- Premixed IV solutions and sets covers the market for commercially available premixed drugs and IV injectables containing antibiotics, pain management drugs and cardiovascular agents and others. This market also covers the drug-delivery systems, plastic and glass containers provided along with the above-mentioned drug premixes marketed to care settings only.
This report covers associated regulatory aspects such as innovations and technological improvements (patents and approvals), latest trends, preferences and progress in the field of IV therapy. In addition, the study also covers the market projections, market leaders and market shares for the global IV therapy and vein access market.
The geographical regions covered in the report are North America, Europe and rest of the world markets. The rest of the world segment includes the markets for countries such as India, China, Japan, South Korea, Taiwan, parts of Africa, Australia, New Zealand, etc.
This report also contains a relevant patent analysis and comprehensive company profiles for leaders in the IV therapy and vein access devices industry. The market is dominated by a few major players including B. Braun Melsungen; Baxter International; Becton Dickinson and Co. (CareFusion Corp., C. R. Bard,); Fresenius Kabi; ICU Medical (Hospira); Medtronic.; Smiths Group. (Smiths Medical) Teleflex, Insulet Corp., Tandem Diabetes Care and Nestlé Health Science.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Companion Diagnostics: Technologies and Markets (BIO077F)
- Global Markets, Technologies and Materials for Thin and Ultrathin Films (SMC057D)
- Molecular Farming: Global Markets (CHM187A)
- Exosome Diagnostics, Therapeutics and Research Tools: Global Markets (BIO149E)
- Global Skin Allergy Testing Market (MDS104A)
Report Highlights
The global intravenous (IV) therapy and vein access market should reach $29 billion by 2021 from $21.6 billion in 2016 at a compound annual growth rate (CAGR) of 6.1%, from 2016 to 2021.
Report Includes
- An overview of the global markets and technologies for intravenous (IV) therapy and vein access.
- Analyses of market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Detailed information on the main categories for IV therapy, including ambulatory infusion pumps, central venous access devices, diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps.
- Identification of current products on the market.
- Assessments of the competitive landscape and competitor market shares.
- Profiles of the company related to the industry.
Report Highlights
The global market for intravenous therapy and vein access was $19.3 billion in 2013. The market reached $20.3 billion in 2014 and is expected to reach about $27.2 billion in 2019, registering a compound annual growth (CAGR) of 6.0% over the next five years.
Report Includes
- An overview of the global markets and technologies for intravenous (IV) therapy and vein access.
- Analyses of market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Detailed information on the main categories for IV therapy including ambulatory infusion pumps, central venous access devices, Diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps.
- Identification of current products on the market.
- Assessments of the competitive landscape and competitor market shares.
Report Highlights
- In 2009, the total global intravenous therapy and vein access market reached nearly; $8.8 billion and is forecast to reach $11.2 billion in 2014, a compound annual growth rate (CAGR) of 5%.
- Insulin-infusion pumps are expected to show the greatest demand over the forecast period. This segment was worth $1.1 billion in 2009 and is expected to increase at an 8.1% compound annual growth rate (CAGR) to reach $1.6 billion in 2014.
- The central venous access devices and implantable pumps segment will experience a 5.7% compound annual growth rate (CAGR) over the forecast period. This market was valued at $975 million in 2009 and is expected to reach a value of nearly $1.3 billion in 2014.
Report Highlights
-
U.S. market revenues for IV therapy and vein access were worth more than $4.6 billion in 2005. At an average annual growth rate (AAGR) of 4.2%, the market will reach almost $5.7 billion by 2010.
-
The market is broken down by ambulatory infusion pumps, enteral feeding pumps, peripheral venous access devices, and syringe infusion pumps. Ambulatory fusion pumps and peripheral venous access devices both held approximately 30% of the market share in 2005. Fusion pumps will maintain the majority of the market through the forecast period, holding a 29% share in 2010.
-
The fastest growing market sector will be syringe infusion pumps, which will have an AAGR of approximately 6.8% through the forecast period.
Related Reports
Microbial Products: Technologies, Applications and Global Markets
The global market for microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a compound annual growth rate (CAGR) of 7.4% from 2022 through 2027.
Global Markets for Catheters
The global market for catheters is estimated to increase from $30.8 billion in 2022 to reach $42.5 billion by 2027, at a compound annual growth rate (CAGR) of 6.6% from 2022 through 2027.
Portable Medical Electronic Products: Technologies and Global Markets
The global portable medical equipment products market should reach $92.5 billion by 2027 from $74.1 billion in 2022 at a compound annual growth rate (CAGR) of 4.5% for the forecast period of 2022 to 2027.
Anesthesia and Respiratory Devices: Global Markets
The global anesthesia and respiratory devices market should reach $36.2 billion by 2022 and more than $51 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Recent Reports
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.
Global Cleanroom Technology Market
The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Microelectromechanical Systems (MEMS) in Global Medical Markets
The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More